Status:
COMPLETED
Serratus Anterior Plan Block and Postoperative Pain in Patients Who Underwent Minimally Invasive Cardiac Surgery
Lead Sponsor:
Kahramanmaras Sutcu Imam University
Conditions:
Morphine Consumption
Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Acute postoperative pain is defined as sudden onset pain that develops after stimulation due to surgical intervention. It is most severe in the first 24 hours after surgery and gradually decreases in ...
Detailed Description
Patients between the ages of 18-65 who will undergo minimally invasive cardiac surgery under elective conditions will be included in the study. Patients will be randomized. The patients will be inclu...
Eligibility Criteria
Inclusion
- Between the ages of 18-65,
- Coronary artery patients with normal left ventricular function and scheduled for elective coronary artery bypass surgery,
- Valve diseases for which elective valve replacement is planned with normal left ventricular function,
- Cases of ASD (Atrial Septal Defect) for atrial septal defect closure
- Patients who will have elective valve + coronary artery bypass without left ventricular dysfunction and patients who volunteer to participate in the study,
- No coagulation disorder
- Patients with a platelet count of more than 100,000,
- Patients with good mental status,
- Patients with an ejection difference value (E/F) above 50% will be included in the study.
Exclusion
- Cases that will require emergency and repeat heart surgery,
- With advanced left coronary artery disease and left ventricular dysfunction,
- Receiving preoperative inotropic support therapy for any reason,
- Mitral stenosis with atrial thrombus,
- Patients with low cardiac out put syndrome and E/F below 50%,
- Patients who need intra-aortic balloon pump during surgery,
- Patients with bleeding and coagulation disorders,
- Patients with hepatic and renal dysfunction,
- Patients with Uncontrolled Diabetes Mellitus and Chronic Obstructive Pulmonary Disease,
- Patients allergic to opioids, analgesics and bupivacaine,
- Patients with atrial fibrillation using anticoagulants,
- Patients with cognitive dysfunction
- Patients who do not want to participate in the study will be excluded from the study.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06002867
Start Date
September 1 2023
End Date
April 10 2024
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kahramanmaras Sutcu Imam University Faculty of Medicine
Kahramanmaraş, Turkey (Türkiye), 46040